VIVIDON, INC
Vividon, formerly known as Exotec, develops scalable, turnkey content distribution servers which enable the delivery of multimedia content and services. Its Delivery Server (CDS) is used by broadband ISPs and network service providers in optimizing the delivery of streaming video and audio.
VIVIDON, INC
Industry:
Content Delivery ISP Video Streaming
Founded:
1998-01-01
Address:
Sudbury, Massachusetts, United States
Country:
United States
Total Employee:
51+
Status:
Active
Total Funding:
20 M USD
Similar Organizations
kt media hub
media & content company
Tom&Jerry Pictures
Media contents
Zodiak Active
TV, Digital & Multimedia content
Investors List
Venrock
Venrock investment in Series B - Vividon, Inc
The Carlyle Group
The Carlyle Group investment in Series B - Vividon, Inc
Atlas Venture
Atlas Venture investment in Series B - Vividon, Inc
Atlas Venture
Atlas Venture investment in Series B - Vividon, Inc
The Carlyle Group
The Carlyle Group investment in Series B - Vividon, Inc
Venrock
Venrock investment in Series B - Vividon, Inc
Atlas Venture
Atlas Venture investment in Series A - Vividon, Inc
The Carlyle Group
The Carlyle Group investment in Series A - Vividon, Inc
More informations about "Vividon, Inc"
Vividon, Inc - Crunchbase Company Profile & Funding
Vividon, Inc closed its last funding round on Feb 28, 2001 from a Series B round. Who are Vividon, Inc 's competitors? Alternatives and possible competitors to …See details»
Vividon, Inc - Funding, Financials, Valuation & Investors
Multimedia contentSee details»
STREAMING THE INTERNET - Vividon, Inc. Trademark Registration
Vividon, Inc. Address: 142 North Road Sudbury, MASSACHUSETTS UNITED STATES 01776: Legal Entity Type: Corporation: Legal Entity State: DELAWARE: Documents. Application: …See details»
Vividion Therapeutics Company Profile | Management and
Vividion Therapeutics appears in search results as Vividion Therapeutics Inc, Vividion Therapeutics, Vividon Inc Vividion, Vividion Accounts Payable...See More. Start with Datanyze …See details»
Home — Vividion Therapeutics
Jan 22, 2025 We combine the power of chemoproteomics and covalent chemistry to forge life-changing connections between precision therapeutics and previously undrugged drivers of …See details»
About Us - Vividion Therapeutics
Prior to joining Vividion she was involved in new company formation at Gene Sciences, Inc., Rodin Therapeutics, and Warp Drive Bio, leading chemistry, program management, and early drug development functions. ... After heading …See details»
Michael Poleselli, President of Vivion, Inc.
Mar 9, 2022 Vivion, Inc. Headquarters 929 Bransten Rd. San Carlos, CA 94070 Toll Free: (800) 479-0997 Phone: (650) 595-3600 Fax: (650) 595-2094. Vivion Inc. was founded in 1957 by …See details»
Vividion: Collaborations Worth Billions Of Dollars (VVID)
Jul 31, 2021 Vividion Therapeutics, Inc. is a San Diego, CA based preclinical stage biopharmaceutical company founded in 2013, building upon several years of research efforts at The Scripps Research Institute ...See details»
Vivion, Inc. | WholeFoods Magazine
Vivion, Inc. | WholeFoods Magazine ... Vivion, Inc.See details»
LFA Machines Expands Presence in Ingredients Industry with …
FORT WORTH, Texas, Aug. 26, 2022 /PRNewswire/ -- Under their holding company Operio Group, LFA Machines, a leading global provider of products and services in the tableting and …See details»
Vividion Therapeutics Announces Drug Discovery …
May 19, 2020 Vividion Therapeutics, Inc. is a biotechnology company focused on transforming the future of human health through the creation of highly selective small molecule medicines that drug traditionally ...See details»
Vividion Therapeutics - Crunchbase Company Profile & Funding
Organization. Vividion Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Vividion is a developer of a novel …See details»
Bayer AG Completes its Acquisition of Vividion Therapeutics
SAN DIEGO – August 19, 2021 – Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets …See details»
拜耳20亿美元收购，Vividion化学蛋白质组学取得转化进展，KEAP…
Armstrong 2023年9月18日，拜耳旗下 Vividion Therapeutics 宣布启动KEAP1激动剂VVD-30037治疗实体瘤的一期临床试验。Vividion 为一家聚焦化学蛋白质组学技术的公司，2021年被拜耳 …See details»
Vividion Therapeutics to Expand with New Global Research and ...
San Diego, USA, July 23, 2024 – Vividion Therapeutics, Inc. (Vividion), a clinical stage biopharmaceutical company utilizing novel discovery technologies to unlock high-value, …See details»
Vividion Therapeutics and Roche Jointly Publish Landmark Nature …
Apr 25, 2024 Vividion Therapeutics, Inc., a wholly owned and independently operated subsidiary of Bayer AG acquired in August 2021, is a biopharmaceutical company utilizing novel …See details»
Covalent binding – Vividion | Bayer Global
Nov 7, 2023 Still today, there are many proteins that are known and well-described drivers of cancer but so far it was impossible to target them with current anti-cancer therapies, which is …See details»
Bayer to acquire Vividion for $1.5bn to boost drug discovery …
Aug 5, 2021 The company’s platform can generate various small molecule treatments in different therapeutic areas. The initial focus is on cancer and immunology targets.. On concluding the …See details»
Bayer Strengthens Drug Discovery Platform Through Acquisition of ...
Berlin, Germany, August 5, 2021 – Bayer AG today announced the acquisition of Vividion Therapeutics, Inc. (Vividion), a US-headquartered biopharmaceutical company utilizing novel …See details»
Bayer bets $1.5B that Vividion will help it target the 'undruggable ...
Aug 5, 2021 Sometimes, it takes $1.5 billion to make "one plus one equal three." Bayer wanted to "really transform" its R&D engine under its recently installed pharma R&D leader.See details»